Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'LABILE ENTEROTOXIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 353 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Keller, WCF; Michetti, P
      Vaccination against Helicobacter pylori - an old companion of man

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Millar, DG; Hirst, TR
      Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments

      CELLULAR MICROBIOLOGY
    3. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    4. Barackman, JD; Ott, G; Pine, S; O'Hagan, DT
      Oral administration of influenza vaccine in combination with the adjuvantsLT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunization

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    5. Simmons, CP; Clare, S; Dougan, G
      Understanding mucosal responsiveness: lessons from enteric bacterial pathogens

      SEMINARS IN IMMUNOLOGY
    6. McCluskie, MJ; Weeratna, RD; Payette, PJ; Davis, HL
      The potential of CpG oligodeoxynucleotides as mucosal adjuvants

      CRITICAL REVIEWS IN IMMUNOLOGY
    7. Nashar, TO; Betteridge, ZE; Mitchell, RN
      Evidence for a role of ganglioside GM(1) in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells

      INTERNATIONAL IMMUNOLOGY
    8. Bernardi, A; Galgano, M; Belvisi, L; Colombo, G
      Simulation of carbohydrate-protein interactions: Computer-aided design of a second generation GM1 mimic

      JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
    9. Zevering, Y
      Vaccine against Helicobacter pylori?

      ANNALS OF MEDICINE
    10. Hammond, SA; Guebre-Xabier, M; Yu, JM; Glenn, GM
      Transcutaneous immunization: An emerging route of immunization and potent immunostimulation strategy

      CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
    11. Del Giudice, G; Covacci, A; Telford, JL; Montecucco, C; Rappuoli, R
      The design of vaccines against Helicobacter pylori and their development

      ANNUAL REVIEW OF IMMUNOLOGY
    12. Chen, JR; Liao, CW; Mao, SJT; Weng, CN
      A recombinant chimera composed of repeat region RR1 of Mycoplasma hyopneumoniae adhesin with Pseudomonas exotoxin: in vivo evaluation of specific IgGresponse in mice and pigs

      VETERINARY MICROBIOLOGY
    13. Nedrud, JG
      Helicobacter pylori vaccines: Lessons from small animal models

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    14. Yamamoto, M; McGhee, JR; Hagiwara, Y; Otake, S; Kiyono, H
      Genetically manipulated bacterial toxin as a new generation mucosal adjuvant

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    15. Simmons, CP; Ghaem-Magami, M; Petrovska, L; Lopes, L; Chain, BM; Williams, NA; Dougan, G
      Immunomodulation using bacterialeEnterotoxins

      SCANDINAVIAN JOURNAL OF IMMUNOLOGY
    16. Mulvey, G; Kitov, PI; Marcato, P; Bundle, DR; Armstrong, GD
      Glycan mimicry as a basis for novel anti-infective drugs

      BIOCHIMIE
    17. Nakase, H; Okazaki, K; Tabata, Y; Uchida, K; Uose, S; Ohana, M; Nishi, T; Watanabe, T; Matsuura, M; Hisatsune, H; Matsumura, K; Itoh, T; Kawanami, C; Chiba, T
      Rectal immunization with antigen-containing microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination

      VACCINE
    18. Yura, M; Takahashi, I; Terawaki, S; Hiroi, T; Kweon, MN; Yuki, Y; Kiyono, H
      Nasal administration of cholera toxin (CT) suppresses clinical signs of experimental autoimmune encephalomyelitis (EAE)

      VACCINE
    19. Nagai, T; Suzuki, Y; Kiyohara, H; Susa, E; Kato, T; Nagamine, T; Hagiwara, Y; Tamura, S; Yabe, T; Aizawa, C; Yamada, H
      Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effectiveadjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines

      VACCINE
    20. Lee, MH; Roussel, Y; Wilks, M; Tabaqchali, S
      Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H-pylori infection in mice

      VACCINE
    21. Sutton, P
      Progress in vaccination against Helicobacter pylori

      VACCINE
    22. Pizza, M; Giuliani, MM; Fontana, MR; Monaci, E; Douce, G; Dougan, G; Mills, KHG; Rappuoli, R; Del Giudice, G
      Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants

      VACCINE
    23. Lycke, N; Schon, K
      The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity

      VACCINE
    24. Partidos, CD; Beignon, AS; Semetey, V; Briand, JP; Muller, S
      The bare skin and the nose as non-invasive routes for administering peptide vaccines

      VACCINE
    25. Streatfield, SJ; Jilka, JM; Hood, EE; Turner, DD; Bailey, MR; Mayor, JM; Woodard, SL; Beifuss, KK; Horn, ME; Delaney, DE; Tizard, IR; Howard, JA
      Plant-based vaccines: unique advantages

      VACCINE
    26. Lauterslager, TGM; Florack, DEA; van der Wal, TJ; Molthoff, JW; Langeveld, JPM; Bosch, D; Boersma, WJA; Hilgers, LAT
      Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B

      VACCINE
    27. Hagiwar, Y; Tsuji, T; Iwasaki, T; Kadowaki, S; Asanuma, H; Chen, Z; Komase, K; Suzuki, Y; Aizawa, C; Kurata, T; Tamura, S
      Effectiveness and safety of mutant Escherichia coli heat-labile enterotoxin (LT H44A) as an adjuvant for nasal influenza vaccine

      VACCINE
    28. Jodar, L; Duclos, P; Milstien, JB; Griffiths, E; Aguado, MT; Clements, CJ
      Ensuring vaccine safety in immunization programmes - a WHO perspective

      VACCINE
    29. Hagiwara, Y; Iwasaki, T; Asanuma, H; Sato, Y; Sata, T; Aizawa, C; Kurata, T; Tamura, S
      Effects of intranasal administration of cholera toxin (or Escherichia coliheat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain

      VACCINE
    30. Isaka, M; Yasuda, Y; Mizokami, M; Kozuka, S; Taniguchi, T; Matano, K; Maeyama, J; Mizuno, K; Morokuma, K; Ohkuma, K; Goto, N; Tochikubo, K
      Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

      VACCINE
    31. Woodland, DL; Hogan, RJ; Zhong, WM
      Cellular immunity and memory to respiratory virus infections

      IMMUNOLOGIC RESEARCH
    32. Alsahli, M; Farrell, RJ; Michetti, P
      Vaccines: An ongoing promise?

      DIGESTIVE DISEASES
    33. Lencer, WI
      Microbes and Microbial Toxins: Paradigms for Microbial-Mucosal Interactions - V. Cholera: invasion of the intestinal epithelial barrier by a stably folded protein toxin

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    34. Davis, SS
      Nasal vaccines

      ADVANCED DRUG DELIVERY REVIEWS
    35. Boyaka, PN; McGhee, JR
      Cytokines as adjuvants for the induction of mucosal immunity

      ADVANCED DRUG DELIVERY REVIEWS
    36. Vajdy, M; O'Hagan, DT
      Microparticles for intranasal immunization

      ADVANCED DRUG DELIVERY REVIEWS
    37. Clark, MA; Jepson, MA; Hirst, BH
      Exploiting M cells for drug and vaccine delivery

      ADVANCED DRUG DELIVERY REVIEWS
    38. Singh, M; Briones, M; O'Hagan, DT
      A novel bioadhesive intranasal delivery system for inactivated influenza vaccines

      JOURNAL OF CONTROLLED RELEASE
    39. Ryan, EJ; Daly, LM; Mills, KHG
      Immunomodulators and delivery systems for vaccination by mucosal routes

      TRENDS IN BIOTECHNOLOGY
    40. Gariepy, J; Kawamura, K
      Vectorial delivery of macromolecules into cells using peptide-based vehicles

      TRENDS IN BIOTECHNOLOGY
    41. Kusters, JG
      Recent developments in Helicobacter pylori vaccination

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    42. Scott, ME; Dossani, ZY; Sandkvist, M
      Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    43. Kong, QX; Richter, L; Yang, YF; Arntzen, CJ; Mason, HS; Thanavala, Y
      Oral immunization with hepatitis B surface antigen expressed in transgenicplants

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    44. Aman, AT; Fraser, S; Merritt, EA; Rodigherio, C; Kenny, M; Ahn, M; Hol, WGJ; Williams, NA; Lencer, WI; Hirst, TR
      A mutant cholera toxin B subunit that binds GM1-ganglioside but lacks immunomodulatory or toxic activity

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    45. Guerrero, RA; Ball, JM; Krater, SS; Pacheco, SE; Clements, JD; Estes, MK
      Recombinant Norwalk virus-like particles administered intranasally to miceinduce systemic and mucosal (fecal and vaginal) immune responses

      JOURNAL OF VIROLOGY
    46. Tumpey, TM; Renshaw, M; Clements, JD; Katz, JM
      Mucosal delivery of inactivated influenza vaccine induces B-cell-dependentheterosubtypic cross-protection against lethal influenza a H5N1 virus infection

      JOURNAL OF VIROLOGY
    47. Daniell, H; Lee, SB; Panchal, T; Wiebe, PO
      Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts

      JOURNAL OF MOLECULAR BIOLOGY
    48. Saito, M; Otake, S; Ohmura, M; Hirasawa, M; Takada, K; Mega, J; Takahashi, I; Kiyono, H; McGhee, JR; Takeda, Y; Yamamoto, M
      Protective immunity to Streptococcus mutans induced by nasal vaccination with surface protein antigen and mutant cholera toxin adjuvant

      JOURNAL OF INFECTIOUS DISEASES
    49. Boirivant, M; Fuss, IJ; Ferroni, L; De Pascale, M; Strober, W
      Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis

      JOURNAL OF IMMUNOLOGY
    50. Simmons, CP; Hussell, T; Sparer, T; Walzl, G; Openshaw, P; Dougan, G
      Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8(+) T cell responses

      JOURNAL OF IMMUNOLOGY
    51. Rodighiero, C; Fujinaga, Y; Hirst, TR; Lencer, WI
      A cholera toxin B-subunit variant that binds ganglioside G(M1) but fails to induce toxicity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    52. Jobling, MG; Holmes, RK
      Biological and biochemical characterization of variant A subunits of cholera toxin constructed by site-directed mutagenesis

      JOURNAL OF BACTERIOLOGY
    53. Ghaem-Maghami, M; Simmons, CP; Daniell, S; Pizza, M; Lewis, D; Frankel, G; Dougan, G
      Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium

      INFECTION AND IMMUNITY
    54. George-Chandy, A; Eriksson, K; Lebens, M; Nordstrom, I; Schon, E; Holmgren, J
      Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells

      INFECTION AND IMMUNITY
    55. Smith, DJ; King, WF; Barnes, LA; Trantolo, D; Wise, DL; Taubman, MA
      Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glucosyltransferase peptide vaccines

      INFECTION AND IMMUNITY
    56. Soriani, M; Williams, NA; Hirst, TR
      Escherichia coli enterotoxin B subunit triggers apoptosis of CD8(+) T cells by activating transcription factor c-Myc

      INFECTION AND IMMUNITY
    57. Sandkvist, M
      Type II secretion and pathogenesis

      INFECTION AND IMMUNITY
    58. Kotloff, KL; Sztein, MB; Wasserman, SS; Losonsky, GA; DiLorenzo, SC; Walker, RI
      Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

      INFECTION AND IMMUNITY
    59. Tsuji, N; Suzuki, K; Kasuga-Aoki, H; Matsumoto, Y; Arakawa, T; Ishiwata, K; Isobe, T
      Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A-suum infection in mice

      INFECTION AND IMMUNITY
    60. Goetsch, LN; Gonzalez, A; Plotnicky-Gilquin, H; Haeuw, JF; Aubry, JP; Beck, A; Bonnefoy, JY; Corvia, N
      Targeting of nasal mucosa-associated antigen-presenting cells in vivo withan outer membrane protein a derived from Klebsiella pneumoniae

      INFECTION AND IMMUNITY
    61. Martin, M; Hajishengallis, G; Metzger, DJ; Michalek, SM; Connell, TD; Russell, MW
      Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) Tcells

      INFECTION AND IMMUNITY
    62. Chies, MD; Martensen, PM; Simmons, C; Porakishvili, N; Justesen, J; Dougan, G; Roitt, IM; Delves, PJ; Lund, T
      Refocusing of B-cell responses following a single amino acid substitution in an antigen

      IMMUNOLOGY
    63. Lavelle, EC; Grant, G; Pusztai, A; Pfuller, U; O'Hagan, DT
      The identification of plant lectins with mucosal adjuvant activity

      IMMUNOLOGY
    64. Kim, JK; Takahashi, I; Kai, Y; Kiyono, H
      Influence of enterotoxin on mucosal intranet: selective inhibition of extrathymic T cell development in intestinal intraepithelial lymphocytes by oral exposure to heat-labile toxin

      EUROPEAN JOURNAL OF IMMUNOLOGY
    65. Spangler, BD; Wilkinson, EA; Murphy, JT; Tyler, BJ
      Comparison of the Spreeta (R) surface plasmon resonance sensor and a quartz crystal microbalance for detection of Escherichia coli heat-labile enterotoxin

      ANALYTICA CHIMICA ACTA
    66. Fujihashi, K; Kato, H; van Ginkel, FW; Koga, T; Boyaka, PN; Jackson, RJ; Kato, R; Hagiwara, Y; Etani, Y; Goma, I; Fujihashi, K; Kiyono, H; McGhee, JR
      A revisit of mucosal IgA immunity and oral tolerance

      ACTA ODONTOLOGICA SCANDINAVICA
    67. Williams, NA
      Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic

      INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    68. Pizza, M; Giuliani, MM; Fontana, MR; Douce, G; Dougan, G; Rappuoli, R
      LTK63 and LTR72, two mucosal adjuvants ready for clinical trials

      INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    69. Eyles, JE; Williamson, ED; Alpar, HO
      Intranasal administration of influenza vaccines - Current status

      BIODRUGS
    70. McCluskie, MJ; Weeratna, RD; Davis, HL
      Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigendistribution

      MOLECULAR MEDICINE
    71. Humbert, J; Jouve, M; Le Bouguenec, C; Gounon, P
      Electron microscopic improvement in the study of diarrheagenic Escherichiacoli

      MICROSCOPY RESEARCH AND TECHNIQUE
    72. Vogel, FR
      Improving vaccine performance with adjuvants

      CLINICAL INFECTIOUS DISEASES
    73. Dougan, G; Ghaem-Maghami, M; Pickard, D; Frankel, G; Douce, G; Clare, S; Dunstan, S; Simmons, C
      The immune responses to bacterial antigens encountered in vivo at mucosal surfaces

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    74. Bernardi, A; Carrettoni, L; Ciponte, AG; Monti, D; Sonnino, S
      Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: Replacement of the sialic acid moiety

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    75. Fan, EK; Merritt, EA; Verlinde, CLMJ; Hol, WGJ
      AB(5) toxins: structures and inhibitor design

      CURRENT OPINION IN STRUCTURAL BIOLOGY
    76. Rask, C; Holmgren, J; Fredriksson, M; Lindblad, M; Nordstrom, I; Sun, JB; Czerkinsky, C
      Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice

      CLINICAL AND EXPERIMENTAL ALLERGY
    77. Turvill, JL; Farthing, MJG
      Role of the neuroendocrine system in pathogenesis of gastroenteritis

      CURRENT OPINION IN INFECTIOUS DISEASES
    78. Konieczny, MPJ; Suhr, M; Noll, A; Autenrieth, IB; Schmidt, MA
      Cell surface presentation of recombinant (poly-) peptides including functional T-cell epitopes by the AIDA autotransporter system

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    79. Mestecky, J; Russell, MW
      Induction of mucosal immune responses in the human genital tract

      FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
    80. Rask, C; Fredriksson, M; Lindblad, M; Czerkinsky, C; Holmgren, J
      Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant

      APMIS
    81. de Haan, A; van Scharrenburg, GJM; Masihi, KN; Wilschut, J
      Evaluation of a liposome-supplemented intranasal influenza subunit vaccinein a murine model system: Induction of systemic and local mucosal immunity

      JOURNAL OF LIPOSOME RESEARCH
    82. Blanchard, TG; Czinn, SJ
      Immunology of Helicobacter pylori and prospects for vaccine

      GASTROENTEROLOGY CLINICS OF NORTH AMERICA
    83. FitzGerald, D; Mrsny, RJ
      New approaches to antigen delivery

      CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
    84. Corthesy-Theulaz, I; Michetti, P
      What's new in anti-Helicobacter pylori vaccination?

      GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
    85. Zamora, J; Reinhardt, G; Polette, M; Macias, P
      Rapid detection in diagnosis of toxigenic Escherichia coli strains LT and VT producing

      ARCHIVOS DE MEDICINA VETERINARIA
    86. Sutton, P; Lee, A
      Helicobacter pylori vaccines - the current status

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    87. Greer, CE; Petracca, R; Buonamassa, DT; Di Tommaso, A; Gervase, B; Reeve, RL; Ugozzoli, M; Van Nest, G; De Magistris, MT; Bensi, G
      The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles

      VACCINE
    88. Sasaki, K; Asano, Y; Honma, Y; Kamiya, N; Handa, T; Ichinose, Y; Yokochi, T; Shiraki, K; Tsuji, T
      Adjuvant action of Escherichia coli enterotoxin for delayed-type hypersensitivity to Oka vaccine virus on pernasal co-administration in mice

      VACCINE
    89. McCluskie, MJ; Davis, HL
      Oral, intrarectal and intranasal immunizations using CpG and non-CpG oligodeoxynucleotides as adjuvants

      VACCINE
    90. Fontana, MR; Monaci, E; Liu, YQ; Qi, GM; Duan, GC; Rappuoli, R; Pizza, M
      IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin

      VACCINE
    91. Tebbey, PW; Scheuer, CA; Peek, JA; Zhu, DZ; LaPierre, NA; Green, BA; Phillips, ED; Ibraghimov, AR; Eldridge, JH; Hancock, GE
      Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H

      VACCINE
    92. Enioutina, EY; Visic, D; Daynes, RA
      The induction of systemic and mucosal immune responses to antigen-adjuvantcompositions administered into the skin: alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity

      VACCINE
    93. Enioutina, EY; Visic, DM; Daynes, RA
      Enhancement of common mucosal immunity in aged mice following their supplementation with various antioxidants

      VACCINE
    94. Baldridge, JR; Yorgensen, Y; Ward, JR; Ulrich, JT
      Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

      VACCINE
    95. Morris, CB; Cheng, E; Thanawastien, A; Cardenas-Freytag, L; Clements, JD
      Effectiveness of intranasal immunization with HIV-gp160 and an HIV-1 Env CTL epitope peptide (E7) in combination with the mucosal adjuvant LT(R192G)

      VACCINE
    96. Kozuka, S; Yasuda, Y; Isaka, M; Masaki, N; Taniguchi, T; Matano, K; Moriyama, A; Ohkuma, K; Goto, N; Udaka, S; Tochikubo, K
      Efficient extracellular production of recombinant Escherichia coli heat-labile enterotoxin B subunit by using the expression/secretion system of Bacillus brevis and its mucosal immunoadjuvanticity

      VACCINE
    97. Fujihashi, K; Koga, T; McGhee, JR
      Mucosal vaccination and immune responses in the elderly

      VACCINE
    98. Sandvig, K; van Deurs, B
      Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives

      EMBO JOURNAL
    99. Tsuji, T; Asano, Y; Handa, T; Honma, Y; Ichinose, Y; Yokochi, T
      Induction of apoptosis in lymphoid tissues of mice after intramuscular injection of enterotoxigenic Escherichia coli enterotoxin

      IMMUNOBIOLOGY
    100. Chen, HM
      Recent advances in mucosal vaccine development

      JOURNAL OF CONTROLLED RELEASE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 07:53:13